42 matches.
- Media CoverageFeatured in Law360: Epstein Becker Green Adds Research Compliance Pro Elizabeth McEvoy2 minute read
- Firm AnnouncementsEpstein Becker Green Welcomes High-Stakes Research Misconduct Attorney and Litigator Elizabeth J. McEvoy, Improves Bench Amid Federal Enforcement Surge3 minute read
- EventsPRIM&R Annual Conference: Decentralized Clinical Trials and the Community Dimension - Advantages and Challenges2 minute read
- EventsMAGI@home 2024: Collaboration Over Confrontation - CTA Negotiation Tips & Tricks1 minute read
- EventsCombination Products Summit: Regulatory and Technical Considerations for On-Body Delivery Systems (OBDS)1 minute read
- Media CoverageMarylana Saadeh Helou Quoted in “FDA Offers Road Map for Remote Trials, but Questions Linger”2 minute read
- Media CoverageKate Heffernan Quoted in “Colleges Get More Leeway to Handle Research Misconduct”2 minute read
- Media CoverageKate Heffernan Quoted in “The Rise of the Science Sleuths”5 minute read
- Media CoverageBBA Spotlight Series: Get to Know Emerging Leaders in Boston Law–Marylana Saadeh Helou8 minute read
- BlogsPodcast: The Future of Laboratory Testing Just Got a Little Clearer - FDA's Final Rule on LDTs – Diagnosing Health Care2 minute read
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs- PublicationsFDA Issues Long-Anticipated Draft Guidance on Diversity Action Plans16 minute read
- EventsAHLA Annual Meeting 20243 minute read
- EventsBCBS Association: Legal and Regulatory Challenges in Psychedelic Research and Commercialization2 minute read
- EventsBCBS Association: The World of Emerging Therapies and Alternative Substances in Healthcare2 minute read
FDA Releases Laboratory-Developed Tests Final Rule- Media CoverageKate Heffernan Featured in AHLA’s Speaking of Health Law Podcast, “Trends Related to Research Misconduct”1 minute read
- Media CoverageEpstein Becker Green Attorneys Elected to Law360’s 2024 Editorial Advisory Boards3 minute read
- PublicationsFDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research Participants9 minute read
- Media CoverageJames Boiani Quoted in “FDA Moving Quickly on LDT Rulemaking as 2024 Elections, 2027 User Fee Renewal Loom”2 minute read
-
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
-
Post-Dobbs: One Year Later
- Media CoverageRobert Hearn Quoted in “Surveying Laboratory Tests from a Health IT Perspective”3 minute read
- Firm AnnouncementsJessika Tuazon Named to the 2023 Southern California Rising Stars List6 minute read
-
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
- PublicationsBradley Merrill Thompson Quoted in “FDA’s Human Factors Draft Draws Fire for Introduction of ‘Critical Task’ Concept”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Outlines Plan for Digital Health Technologies for Clinical Trials”4 minute read
-
Direct Access Laboratory Testing: Reimbursement & Compliance
-
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
- EventsAdvanced Topics in Clinical Research2 minute read
-
Post-Dobbs: Considerations for Clinical Trials and Research
- Media CoverageJames Boiani Quoted in “Congress Has a Chance to Close the FDA’s Theranos Loophole”3 minute read
Firm AnnouncementsEpstein Becker Green Announces 2023 PromotionsOctober 28, 20225 minute read- Firm AnnouncementsEpstein Becker Green’s Amy Dow Honored in Crain’s 2022 Notable Women in Law2 minute read
- PublicationsOHRP Draft Guidance on the Use of Single IRBs: Reminder to Comment by August 308 minute read
- EventsNWABR Hybrid IRB Conference: Privacy Pile-Up—Making Sense of Multiple Frameworks for Research Participant Privacy and Data ProtectionJuly 28, 20221 minute read
- Firm AnnouncementsJessika Tuazon Named to the 2022 Southern California Rising Stars List5 minute read
- EventsMicrofluidics to Address Pandemics - SARS-CoV-2 and Beyond2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Clinical Decision Support Guidance Tops FDA’s Agenda for 2022”2 minute read
- EventsAHLA: Legal Issues Surrounding the Secondary Use of Health Data2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA's 2022 A-List Guidance Plan Hits on Software, Post-Pandemic Future”4 minute read
- EventsHealth Insights Fall 2021 Conference: Recognizing the Value of Patient Data Assets1 minute read
